Ernexa Therapeutics, Inc. (ERNA)
12.46
+1.06
(+9.30%)
USD |
NASDAQ |
May 21, 16:00
12.70
+0.24
(+1.93%)
After-Hours: 19:59
Ernexa Therapeutics Research and Development Expense (TTM) : 4.762M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Quince Therapeutics, Inc. | 34.08M |
| Recursion Pharmaceuticals, Inc. | 382.53M |
| Tango Therapeutics, Inc. | 127.14M |
| Aprea Therapeutics, Inc. | 6.171M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |